| Product NDC: | 0173-0712 |
| Proprietary Name: | AVODART |
| Non Proprietary Name: | dutasteride |
| Active Ingredient(s): | .5 mg/1 & nbsp; dutasteride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0712 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021319 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20021210 |
| Package NDC: | 0173-0712-02 |
| Package Description: | 7 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0173-0712-02) |
| NDC Code | 0173-0712-02 |
| Proprietary Name | AVODART |
| Package Description | 7 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0173-0712-02) |
| Product NDC | 0173-0712 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dutasteride |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 20021210 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | DUTASTERIDE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] |